Search Results - "Skupa, Sydney A"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies by Upadhyay Banskota, Shristi, Skupa, Sydney A, El-Gamal, Dalia, D'Angelo, Christopher R

    “…The gut microbiome is increasingly being recognized as an important immunologic environment, with direct links to the host immune system. The scale of the gut…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax by Eiken, Alexandria P, Schmitz, Elizabeth, Drengler, Erin M, Smith, Audrey L, Skupa, Sydney A, Mohan, Kabhilan, Rana, Sandeep, Singh, Sarbjit, Mallareddy, Jayapal Reddy, Mathew, Grinu, Natarajan, Amarnath, El-Gamal, Dalia

    Published in Hemato (01-09-2024)
    “…B-cell receptor (BCR) signaling is a central driver in chronic lymphocytic leukemia (CLL), along with the activation of pro-survival pathways (e.g., NF-κB) and…”
    Get full text
    Journal Article
  4. 4

    Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia by Zablonski, Kevin G, Skupa, Sydney A, Eiken, Alexandria P, Sundaram, Suchitra, Mavis, Cory, Gu, Juan Jenny, Torka, Pallawi, Ghione, Paola, El-Gamal, Dalia, Hernandez-Ilizaliturri, Francisco J

    Published in Leukemia & lymphoma (27-09-2024)
    “…Chronic lymphocytic leukemia (CLL) remains incurable and its ability to acquire resistance to front-line therapeutics has proved challenging. Bromodomain and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Comparison of Dietary Intake and Dietary Inflammatory Index in Patients with Chronic Lymphocytic Leukemia By Treatment Status to Cohabitating Controls by D'Angelo, Christopher R, Rasmussen, Heather, Yu, Fang, Skupa, Sydney A, El-Gamal, Dalia

    Published in Blood (02-11-2023)
    “…Chronic lymphocytic leukemia (CLL) is an incurable disease with a varied presentation ranging from indolent and asymptomatic to morbid and life-limiting. As…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Progressive Gut Microbiome Dysbiosis Is Associated with Chronic Lymphocytic Leukemia Pathogenesis and Development in the Eµ-TCL1 Mouse Model by Skupa, Sydney A, Smith, Audrey L, Eiken, Alexandria P, Schmitz, Elizabeth A, Cooper, Kathryn M, D'Angelo, Christopher R, El-Gamal, Dalia

    Published in Blood (02-11-2023)
    “…Introduction: The gut microbiome is home to a community of microorganisms such as bacteria, fungi, viruses, archaea, and protozoa. Maintaining a balance…”
    Get full text
    Journal Article
  10. 10

    BET Inhibition As a Targeted Epigenetic Approach to Reverse T Cell Dysfunction in Chronic Lymphocytic Leukemia by Smith, Audrey L, Eiken, Alexandria P, Skupa, Sydney A, Moore, Dalia Y, Kallam, Avyakta, D'Angelo, Christopher, Bociek, Gregory R, Lunning, Matthew A., Vose, Julie M., Powell, Ben, Bollag, Gideon, ElGamal, Dalia

    Published in Blood (23-11-2021)
    “…Introduction: Chronic Lymphocytic Leukemia (CLL) is characterized by the clonal expansion of mature CD19+/CD5+ lymphocytes in the peripheral blood and…”
    Get full text
    Journal Article
  11. 11

    Abstract 6396: BET inhibition alleviates T-cell dysfunction in chronic lymphocytic leukemia by Smith, Audrey L., Eiken, Alexandria P., Skupa, Sydney A., D'Angelo, Christopher R., Kallam, Avyakta, Lunning, Matthew A., Bociek, Gregory, Vose, Julie M., Powell, Ben, Bollag, Gideon, El-Gamal, Dalia

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Background: The chronic lymphocytic leukemia (CLL) tumor microenvironment (TME) is laden with hyporesponsive T-cells that permit disease persistence…”
    Get full text
    Journal Article